Equities
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (SEK)278.50
  • Today's Change0.50 / 0.18%
  • Shares traded2.55k
  • 1 Year change-8.69%
  • Beta--
Data delayed at least 15 minutes, as of May 08 2024 12:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Essity AB (publ) is a Sweden-based hygiene and health company that develops, produces, markets and sells personal care and tissue products. The Company conducts sales in about 150 countries under such brands, as TENA for incontinence products and Tork for Away-from-Home tissue, as well as under other brands, such as Bodyform, Velvet, Cushelle and Plenty. The Company’s medical brands comprise Leukoplast, Cutimed, JOBST, Delta Cast, Delta Lite and Actimove.

  • Revenue in SEK (TTM)139.07bn
  • Net income in SEK9.24bn
  • Incorporated1988
  • Employees36.01k
More ▼

Institutional shareholders

30.75%Per cent of shares held by top holders
HolderShares% Held
AMF Fonder ABas of 29 Dec 20237.35m12.06%
Norges Bank Investment Managementas of 29 Dec 20235.90m9.68%
Skandia Investment Management ABas of 29 Dec 20232.10m3.44%
MFS International Singapore Pte. Ltd.as of 31 Mar 2024864.31k1.42%
Sjunde AP-fondenas of 29 Feb 2024752.56k1.23%
Keskin�inen El�kevakuutusyhti� Ilmarinenas of 31 Dec 2022456.44k0.75%
KBC Fund Management Ltd.as of 31 Dec 2023417.87k0.69%
Pyrford International Ltd.as of 30 Jun 2022338.26k0.56%
Mercer Global Investments Europe Ltd.as of 30 Jun 2023313.34k0.51%
Mawer Investment Management Ltd.as of 31 Oct 2023256.94k0.42%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.